Home » Topics » Disease categories and therapies » Urology

Urology
RSS

R&D at Sanofi-Synthelabo leads to identification of potent PDE5 inhibitors

Nov. 27, 2000

Novel steroidal aromatase inhibitor TZA-2237 tested in dog models of BPH

Nov. 27, 2000

Sildenafil tested in patients with LVD

Nov. 24, 2000

Potential new treatments for urinary incontinence described by Sanofi-Synthelabo

Nov. 20, 2000

Triarylimidazoles synthesized at SmithKline Beecham active as inhibitors of TGF-beta signaling

Nov. 20, 2000

Team from Roche Bioscience identifies new target for the treatment of overactive bladder

Nov. 17, 2000

Research at Neurogen leads to identification of new B2 receptor modulators

Nov. 13, 2000

Investigational drug for ED discovered by Fujisawa now licensed to TAP

Nov. 10, 2000

Phase II trial results for Alprox-TD in ED announced by NexMed

Nov. 8, 2000

Actinomycin D presented in Singapore as potential stroke-related incontinence therapy

Nov. 7, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...